New group therapy shows promise for easing anxiety and depression

NCT ID NCT06863948

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new type of group therapy called Terebenin's Method for adults with mild to moderate anxiety and depression. The therapy combines role-playing, body awareness, and guided discussion in weekly sessions over 8 weeks. Researchers measured changes in symptoms and stress-related biomarkers like cortisol. The goal was to see if this approach could help reduce anxiety and depression and to gather data for a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Terebenin's Method (integrative group psychotherapy combining psychodrama, systemic constellation, body-oriented practices, and directive therapy)
What this could lead to
If it works, this could offer a new group therapy option for people with mild to moderate anxiety and depression, potentially reducing symptoms and stress.
What could go wrong
This is a small pilot study with only 66 participants, so results may not apply to everyone. It's early-stage research, and the therapy may not prove more effective than standard treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for New Medical Technologies

    Novosibirsk, 630090, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.